Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Scancell Holdings (SCP0) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Iscib1+, Nivolumab & Ipilimumab, Yervoy, OpdivoSkin Cancer, Metastatic Melanoma, Advanced Melanoma, Melanoma (Skin Cancer)Phase IIINot Yet RecruitingiSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable MelanomaSep 03, 2026―
Pembrolizumab, Modi-1 Moditope, Micronjet600 Microneedle DeviceTriple Negative Breast Cancer, Squamous Cell Carcinoma Of The Head And Neck, Renal Cell Cancer, High Grade Ovarian Serous Adenocarcinomaphase1AndPhase2RecruitingModi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal CancerJan 31, 2022
Scib1 Or Iscib1+ Dna VaccineMalignant Melanoma, Melanoma Stage Iii, Melanoma Stage Iv, Melanoma (Skin)Phase IIRecruitingSCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)Aug 16, 2019

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Scancell Holdings (DE:SCP0) have in its pipeline
Scancell Holdings DE:SCP0 is currently developing the following drugs: Iscib1+, Nivolumab & Ipilimumab, Yervoy, Opdivo, Pembrolizumab, Modi-1 Moditope, Micronjet600 Microneedle Device, Scib1 Or Iscib1+ Dna Vaccine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.